Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker STOK
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Oct 29, 2026 | STOK Stoke Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Sep 25, 2026 | STOK Stoke Therapeutics, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Aug 3, 2026 | STOK Stoke Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Aug 3, 2026 | STOK Stoke Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jun 30, 2026 | STOK Stoke Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jun 30, 2026 | STOK Stoke Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jun 4, 2026 | STOK Stoke Therapeutics, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 7, 2026 | STOK Stoke Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Apr 7, 2026 | STOK Stoke Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Apr 7, 2026 | STOK Stoke Therapeutics, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Mar 27, 2026 | STOK Stoke Therapeutics, Inc. | 4.01 Changes in Registrant's Certifying Accountant | 8-K | 8-K ↗ |
| Mar 3, 2026 | STOK Stoke Therapeutics, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Jan 26, 2026 | STOK Stoke Therapeutics, Inc. | 2.03 Creation of a Direct Financial Obligation | 8-K | 8-K ↗ |
| Jan 26, 2026 | STOK Stoke Therapeutics, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jan 12, 2026 | STOK Stoke Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jan 12, 2026 | STOK Stoke Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jan 12, 2026 | STOK Stoke Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Dec 5, 2025 | STOK Stoke Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Dec 5, 2025 | STOK Stoke Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 4, 2025 | STOK Stoke Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Oct 6, 2025 | STOK Stoke Therapeutics, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Sep 18, 2025 | STOK Stoke Therapeutics, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K/A | 8-K ↗ |
| Aug 12, 2025 | STOK Stoke Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Aug 12, 2025 | STOK Stoke Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Aug 11, 2025 | STOK Stoke Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jul 10, 2025 | STOK Stoke Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jun 4, 2025 | STOK Stoke Therapeutics, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Jun 4, 2025 | STOK Stoke Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jun 4, 2025 | STOK Stoke Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| May 13, 2025 | STOK Stoke Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Mar 18, 2025 | STOK Stoke Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Mar 18, 2025 | STOK Stoke Therapeutics, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Mar 18, 2025 | STOK Stoke Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Feb 18, 2025 | STOK Stoke Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Feb 18, 2025 | STOK Stoke Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Feb 18, 2025 | STOK Stoke Therapeutics, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jan 7, 2025 | STOK Stoke Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jan 7, 2025 | STOK Stoke Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Dec 6, 2024 | STOK Stoke Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Dec 6, 2024 | STOK Stoke Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 5, 2024 | STOK Stoke Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
41 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 4:37 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances